DEPLOYDatabase

Company

Paradromics

Paradromics is an Austin-based neurotechnology company developing the Connexus BCI, a high data-rate fully implantable brain-computer interface for restoring…

Status
Private

CategoryBiometric wearables

Overview

Paradromics is an Austin-based neurotechnology company developing the Connexus BCI, a high data-rate fully implantable brain-computer interface for restoring speech and computer control in people with severe motor impairment. First human implantation completed June 2026 at University of Michigan Health as part of the FDA-approved Connect-One clinical trial.

Verified record

Verified deployments
2 deployments on file
Active incidents
None on file

Key facts

FDA

IDE approved + Breakthrough Device

Fundingsee investors →

$33M Series A (Prime Movers Lab)

Data rate

200+ bits/sec

Product

Connexus BCI (fully implantable)

Data & sources

Web sources

1

1 source backing this record.View all →

Current leadership (1)

Founders (1)

See all founders across the registry →

Safety record

No incidents on record for Paradromics.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Operator customers (1)

Recent coverage

Paradromics in third-party press

Peers

3 peers across 1 segment. Every Paradromics competitor derived from shared form-factor and application-domain edges.

bci(3)

3 companies in this segment · highly_concentrated (HHI 3365.5523463639224) · leader Blackrock Neurotech at 3565%

Mentioned on (2)

Registry pages whose text names Paradromics.

Robots and products (1)

Connexus BCI

People (1)

Matt Angle